The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

CHARLOTTESVILLE, Va. (WVIR) - According to one UVA health expert, antidepressants, and medication prescribed to help people ...

With the new year here and winter weather upon us, many people are dealing with seasonal depression.Studies show that ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...